Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD
Nicholas C Chesnaye(Amsterdam Neuroscience), Silke Röser, Anke Torp, Nikolaus Frischmuth, Christian Marx, Kai Hahn, Justyna Mazur, Ines Schlee, Sabine Aign, Claudia Torino(Istituto di Fisiologia Clinica), Kirsten Anding‐Rost, Katja Blouin, Holger Naujoks, Christoph Wanner(Universitätsklinikum Würzburg), Eva Platen, Marie Evans(Karolinska University Hospital), Monika Hopf, Pawlos Ichtiaris, Olof Heimbürger(Karolinska University Hospital), Kitty J. Jager(Amsterdam University Medical Centers), Katrin Neumeier, Christiane Drechsler(Universitätsklinikum Würzburg), Andreas Schneider, Petra Kirste, Sabine Cäsar, Gaetana Porto(Azienda ospedaliera "Bianchi-Melacrino-Morelli"), Petra Schulz, Sandra Biribauer, Sherin Manan, Boris Perras, Dunja Fuchs, Beate Iwig, Joachim Beige, Nadja Wuttke, Esther de Rooij(Leiden University Medical Center), Maciej Szymczak(Wroclaw Medical University), Friedo W. Dekker(Leiden University Medical Center), Hendrik Schlee, Fergus Caskey, Claudia Emde, Maria Pippias(North Bristol NHS Trust), Christof Blaser, Detlef H. Krieter(Universitätsklinikum Würzburg), Hans Schmidt‐Gürtler, Ellen Irmler, Lothar Schramm, Jochen Röthele
Cited by 11
Related Papers
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
|New England Journal of Medicine|2016|3.6k
Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
|Kidney International|1999|1.8k
Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials
|The Lancet|2022|1k
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
|New England Journal of Medicine|2013|990
IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly
|Kidney International|2005|927